A Facile Strategy for Preparation of Yttrium-90 Therapeutic Sources for Radionuclide Therapy.

Mold brachytherapy using high-energy -emitting radioisotopes is a promising treatment modality for skin cancers and keloids. Simple methodologies for consistent and stable incorporation of radionuclides into the matrix are desired for preparation of therapeutic sources. The authors report a facile strategy for the stable incorporation of Yttrium-90 (Y) into amidoxime-functionalized polyacrylonitrile-polyvinylidene fluoride (PAN-PVDF) membranes.

On the Separation of Yttrium-90 from High-Level Liquid Waste: Purification to Clinical-Grade Radiochemical Precursor, Clinical Translation in Formulation of Y-DOTATATE Patient Dose.

The quality control parameters of in-house-produced Y-Acetate from high-level liquid waste (HLLW) using supported liquid membrane (SLM) technology were validated and compared with the pharmacopeia standard. The radiolabeling of DOTATATE yielding Y-DOTATATE in acceptable radiochemical purity (RCP), with expected pharmacological behavior in models, establish the quality of Y-Acetate. Clinical translation of Y-Acetate in formulation of Y-DOTATATE adds support toward its use as clinical-grade radiochemical.

Synthesis and extraction studies with a rationally designed diamide ligand selective to actinide(iv) pertinent to the plutonium uranium redox extraction process.

A new class of conformationally constrained oxa-bridged tricyclo-dicarboxamide (OTDA) ligand was rationally designed for the selective extraction of tetravalent actinides pertinent to the Plutonium Uranium Redox EXtraction (PUREX) process. Two of the designed diamide ligands were synthesized and extraction studies were performed for Pu(iv) from HNO3 medium. The mechanism of extraction was investigated by studying various parameters such as feed HNO3, NaNO3 and OTDA concentrations.

Design, synthesis and extraction studies of a new class of conformationally constrained (N,N,N',N'-tetraalkyl)7-oxabicyclo[2.2.1]heptane-2,3-dicarboxamides.

A new class of conformationally constrained 7-oxabicyclo[2.2.1]heptane-2,3-dicarboxamides (OBDA) of three secondary amines was synthesized, and their extraction behavior for trivalent and tetravalent actinides in HNO3 medium was studied.

Extraction and structural studies of an unexplored monoamide, N,N'-dioctyl, α-hydroxy acetamide with lanthanide(III) and actinide(III) ions.

A monoamide, N,N'-dioctyl, α-hydroxy acetamide, shows unusual extraction properties towards trivalent lanthanide and actinide ions above 3 M HNO3. The extracted ions could be quantitatively back extracted using 0.5 M HNO3.

Bioevaluation of (90)Y-labeled particles in animal model of arthritis.

Objective: The aim of the present study was to evaluate the behaviour of (90)Y-labeled particles when injected into an arthritic knee joint of Wistar rats with severe inflammation induced using Complete Freund's Adjuvant (CFA).

Methods: (90)Y-ferric hydroxide macroaggregates ((90)Y-FHMA), (90)Y-hydroxyapatite ((90)Y-HA) and (90)Y-phosphate particles ((90)YPO(4)) were prepared, subjected to quality control analyses and in vitro stability studies. Biodistribution studies were carried out by intra-articular injection into knee joints of Wistar rats induced with chronic inflammatory arthritis using CFA and by monitoring the radioactivity for retention and leakage.

Extraction paper chromatography technique for the radionuclidic purity evaluation of 90Y for clinical use.

Yttrium-90 used for therapy should be of very high radionuclidic (RN) purity (>99.998%) as the most probable contaminant, strontium-90, is a bone seeker with a maximum permissible body burden of 74 kBq (2 microCi) only. None of the current known methods of RN purity estimations is adequate to reliably measure the 90Sr RN impurity at such low levels.

Evaluation of 90Y phosphate particles as a possible radiation synoviorthesis agent.

Background: 90Y is one of the radioisotopes used extensively for therapy due to its favourable nuclear characteristics. Particles and colloids incorporating 90Y are being used for radiation synovectomy, especially in European countries.

Methods: In our present work, 90Y phosphate particles were prepared and evaluated for use in radiation synovectomy.